LEADER 02896oam  22005535  450 
001 9910484358103321
005 20231211223910.0
010   $a3-030-55989-0
024 7 $a10.1007/978-3-030-55989-2
035   $a(CKB)4100000011743139
035   $a(DE-He213)978-3-030-55989-2
035   $a(MiAaPQ)EBC6465093
035   $a(PPN)253253411
035   $a(EXLCZ)994100000011743139
100   $a20210127d2021      uy             0
101 0 $aeng
135   $aurnn#008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aIndolent lymphomas /$fedited by Martin Dreyling, Marco Ladetto
205   $a1st ed. 2021.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2021.
215   $a1 online resource  (vi, 246 pages) $ccolor illustrations
225 1 $aHematologic Malignancies,$x2197-9774
311 0 $a3-030-55988-2 
327   $aPathology -- Molecular Genetics -- MRD -- Pet Imaging -- Role of Radiotherapy -- Follicular Lymphoma -- MALT -- Nodal Marginal Zone Lymphoma -- Splenic Marginal Zone Lymphom -- Waldenstroem -- Mantle Cell Lymphoma -- Hairy Cell Leukemia -- Chronic Lyphocytic Leukemia -- Mykosis Fungoides -- Large Granular Lymphocytic.
330   $aThis book provides a comprehensive overview of current treatment strategies in indolent lymphomas, the clinical management of which continues to pose significant challenges for the general oncologist despite the tremendous progress in diagnosis, evaluation of risk factors, and molecular targeted approaches. Experts in the field from around the world describe the histomorphology in a clinically relevant manner, consider the role of risk factors in detail, and discuss the full spectrum of therapeutic approaches. Special emphasis is placed on the translation of molecular science into clinical care, and a disease-specific algorithm is proposed for each entity. The coverage encompasses follicular lymphoma, MALT, nodal marginal zone lymphoma, splenic marginal zone lymphoma, Waldenström?s macroglobulinemia, hairy cell leukemia, chronic lymphocytic leukemia, mycosis fungoides, large granular lymphocytic leukemia, and also mantle cell lymphoma. The book will be an excellent resource for experienced and inexperienced practitioners alike.
410  0$aHematologic malignancies (Series)$x2197-9774
606   $aHematology
606   $aOncology
606   $aLymphomas
606   $aHematology
606   $aOncology
615  0$aHematology.
615  0$aOncology.
615  0$aLymphomas.
615 14$aHematology.
615 24$aOncology.
676   $a616.15
702   $aDreyling$b Martin
702   $aLadetto$b Marco
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bUtOrBLW
906   $aBOOK
912   $a9910484358103321
996   $aIndolent lymphomas$92847443
997   $aUNINA